- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03190408
Variation in Fluids Administered in Shock (VOLUME)
July 21, 2020 updated by: Montefiore Medical Center
Observation of Variation in Fluids Administered and Characterization of Vasopressor Requirements in Shock
To conduct a multicenter observational cohort study to determine the variability in fluid resuscitation in shock in a broad range of areas in hospitals and treatment areas.
Study Overview
Study Type
Observational
Enrollment (Actual)
1639
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
New York
-
Bronx, New York, United States, 10461
- Montefiore Medical Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
patients with shock
Description
Inclusion Criteria:
- Age ≥ 18 years admitted to the participating hospital.
- Patients in the emergency department, intensive care unit, PACU, or any hospital floor. For patients not in the ICU, there must be plans to transfer to an intensive care unit when an ICU bed is available for patient.
- Patients with shock as defined by:
- Need for vasopressor (dopamine, norepinephrine, or epinephrine at any dose) to keep MAP > 65 mmHg Or
- Systolic BP < 90 mmHg
Exclusion Criteria:
- Patients previously enrolled into this study.
- Patients who were in the operating room at time of shock and fluid bolus.
- Patients admitted to an ICU after cardiac surgery Patients with primarily cardiogenic shock as etiology for their shock
- Patients transferred from another hospital or emergency room to the study hospital.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Shock
|
Fluids Administered in Shock
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Method used to guide volume resuscitation
Time Frame: 7 days
|
Characterize the method used to guide volume resuscitation and vasopressor use in patients with shock
|
7 days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
September 1, 2017
Primary Completion (Actual)
February 1, 2018
Study Completion (Actual)
February 1, 2018
Study Registration Dates
First Submitted
June 14, 2017
First Submitted That Met QC Criteria
June 14, 2017
First Posted (Actual)
June 16, 2017
Study Record Updates
Last Update Posted (Actual)
July 23, 2020
Last Update Submitted That Met QC Criteria
July 21, 2020
Last Verified
July 1, 2020
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2017-7860
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Shock
-
Assistance Publique - Hôpitaux de ParisTraumabase Group; Capgemini Invent; Ecole polytechnique; EHESS (Ecole des hautes... and other collaboratorsCompletedWounds and Injuries | Hemorrhagic Shock | Traumatic ShockFrance
-
Biomedizinische Forschungs gmbHMedical University of ViennaCompletedSepsis | Toxic-Shock Syndrome
-
Haukeland University HospitalMinistry of Defence, NorwayCompletedHemorrhagic Shock | Hypovolemic ShockNorway
-
King's College Hospital NHS TrustUniversity Hospital BirminghamCompletedTraumatic Haemorrhagic ShockUnited Kingdom
-
National Institute of Allergy and Infectious Diseases...Completed
-
Assiut UniversityUnknown
-
University of ManitobaCanadian Institutes of Health Research (CIHR); CancerCare ManitobaTerminatedSeptic Shock | Vasodilatory ShockCanada, United States, Brazil, Greece, India, Pakistan, Philippines
-
Massachusetts General HospitalBeth Israel Deaconess Medical Center; Boston Medical Center; Tufts Medical Center and other collaboratorsRecruiting
-
Jason SperryNational Heart, Lung, and Blood Institute (NHLBI)TerminatedHemorrhagic ShockUnited States
-
University of Texas Southwestern Medical CenterUniversity of Washington; Resuscitation Outcomes ConsortiumCompletedHemorrhagic ShockUnited States
Clinical Trials on Fluids
-
Esbjerg Hospital - University Hospital of Southern...Odense University Hospital; Hospital of Southern Jutland, Aabenraa, DenmarkRecruiting
-
University of Colorado, DenverCompletedPain, Postoperative | Femoro Acetabular ImpingementUnited States
-
University of AarhusAarhus University HospitalCompletedCoronary Artery Disease | Fluid Overload | HypovolemiaDenmark
-
Cairo UniversityCompletedPost-Dural Puncture HeadacheEgypt
-
University of FoggiaUnknownHypothermia; AnesthesiaItaly
-
Samsung Medical CenterCompleted
-
Ain Shams UniversityArmed Forces Hospitals, Southern Region, Saudi ArabiaCompletedPostoperative CareSaudi Arabia
-
Icahn School of Medicine at Mount SinaiCompletedTransient Tachypnea of the NewbornUnited States
-
Johns Hopkins UniversityRecruitingBladder Cancer | Cystectomy | Muscle Invasive Bladder Cancer Urothelial Carcinoma | Muscle Invasive Bladder Cancer (MIBC)United States
-
University of Rome Tor VergataRecruitingAcute Lymphoblastic LeukemiaItaly